CompaniesKAHR Medical

KAHR Medical

active
Modi'in-Maccabim-Re'ut, Israel
Founded 2005
Website
About

Fusion proteins

Areas of Focus

Categories

Biologics & BiopharmaceuticalMiddle East
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

161

By Phase

PHASE1: 1PHASE1/PHASE2: 2

By Status

ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT02545361
NCT04440735
NCT04937166
Hover over trial bars to see details

Recent Trials

NCT04937166Lead Sponsor
A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
PHASE1Active, not recruiting
36 participants
Started: Jan 13, 2022 · Completed: Jun 30, 2025
NCT04440735Lead Sponsor
A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
125 participants
Started: Oct 7, 2020 · Completed: Sep 30, 2025
NCT02545361Lead Sponsor
Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients
PHASE1/PHASE2Withdrawn
Started: Apr 30, 2018 · Completed: Apr 30, 2020
Locations (1)
Headquarters
Modi'in-Maccabim-Re'ut, Israel
Map

Loading map...